Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases
Authors:
Open Access
- 1 June 2009
- journal article
- Published by Wiley in Journal of Small Animal Practice
- Vol. 50 (6) , 284-289
Abstract
Objectives:To evaluate the response of measurable canine mast cell tumours unsuitable for other treatment modalities to a chemotherapy protocol comprising chlorambucil and prednisolone.Methods:Dogs bearing measurable mast cell tumours, unsuitable for treatment by surgery or radiotherapy, were treated with orally administered prednisolone and chlorambucil, and their responses assessed.Results:Twenty‐one dogs were enrolled in the study; 13 had intermediate‐grade mast cell tumour, six were high grade and two were diagnosed by cytology alone. Eight dogs had multiple tumours and 13 dogs had single tumours, and six dogs had lymph node metastases and no dogs had visceral metastases detected. Three dogs achieved complete remission, five achieved partial remission (overall response rate 38 per cent), nine had static disease and four dogs had progressive disease. Median progression‐free interval for the eight responders was 533 days, and median survival time for all dogs in the study was 140 days. Progression‐free interval and median survival time were not influenced by the age, sex, weight or neutering status of the patient, by the grade or stage of the tumour or whether the patient had single or multiple tumours. No toxicity was detected.ClinicalSignificance:Response and survival rates of inoperable canine MCT to chlorambucil and prednisolone are comparable to previously described protocols, with no apparent toxicity.Keywords
This publication has 30 references indexed in Scilit:
- Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogsJournal of the American Veterinary Medical Association, 2008
- Treatment of canine mast cell tumours with vinblastine, cyclophosphamide and prednisone: 35 cases (1997–2004)Veterinary and Comparative Oncology, 2007
- Vinblastine and prednisolone chemotherapy for surgically excised grade III canine cutaneous mast cell tumoursVeterinary and Comparative Oncology, 2007
- Recurrence Rate, Clinical Outcome, and Cellular Proliferation: Indices as Prognostic Indicators after Incomplete Surgical Excision of Cutaneous Grade II Mast Cell Tumors: 28 Dogs (1994–2002)Journal of Veterinary Internal Medicine, 2006
- Impact of Tumour Depth, Tumour Location and Multiple Synchronous Masses on the Prognosis of Canine Cutaneous Mast Cell TumoursJournal of Veterinary Medicine Series A, 2005
- Treatment of canine mast cell tumours with prednisolone and radiotherapyVeterinary and Comparative Oncology, 2004
- Biologic Behavior and Prognostic Factors for Mast Cell Tumors of the Canine Muzzle: 24 Cases (1990–2001)Journal of Veterinary Internal Medicine, 2003
- Treatment of Canine Mast Cell Tumors with CCNU (Lomustine)Journal of Veterinary Internal Medicine, 1999
- Inhibitory Effects of Glucocorticoids on Proliferation of Canine Mast Cell Tumor.Journal of Veterinary Medical Science, 1997
- A Prospective Study of Radiation Therapy for the Treatment of Grade 2 Mast Cell Tumors in 32 DogsJournal of Veterinary Internal Medicine, 1996